Chemical activators of FBXO41 can be understood through their influence on specific cellular pathways and the resultant biochemical events that lead to the protein's activation. Forskolin, for instance, is known to activate adenylyl cyclase, which catalyzes the conversion of ATP to cyclic AMP (cAMP). An increase in cAMP levels subsequently activates protein kinase A (PKA). PKA can phosphorylate FBXO41, which enhances its ubiquitination activity, a key process in protein regulation and turnover. Similarly, Phorbol 12-myristate 13-acetate (PMA) acts as an activator of protein kinase C (PKC), which phosphorylates FBXO41, thus promoting its activation. Another chemical, Ionomycin, facilitates the increase of intracellular calcium levels that activate calcium-dependent kinases, which in turn can lead to the phosphorylation and activation of FBXO41. Thapsigargin contributes to FBXO41 activation by inhibiting the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), causing a rise in cytosolic calcium, which activates kinases that may phosphorylate FBXO41.
In the realm of enzyme inhibition, compounds like Okadaic Acid and Calyculin A inhibit protein phosphatases PP1 and PP2A. This inhibition prevents the dephosphorylation of proteins, maintaining FBXO41 in a phosphorylated state that is indicative of its active form. Anisomycin activates the JNK pathway, which can lead to the activation of FBXO41 through phosphorylation. Proteasome inhibitors, such as MG132 and Epoxomicin, inhibit the degradation of phosphorylated FBXO41, resulting in the accumulation of the active form of the protein. LY294002 acts by inhibiting PI3K, leading to reduced Akt activity and altering the phosphorylation status of various proteins, which can activate FBXO41. Rapamycin's inhibition of mTOR might also lead to activation of FBXO41 through complex feedback loops that result in its dephosphorylation and activation. Lastly, 6-Benzylaminopurine, a plant hormone known as cytokinin, activates specific kinases that have the capacity to phosphorylate and activate FBXO41. Each of these chemicals acts upon FBXO41 through distinct mechanisms, but all converge on the common outcome of activating the protein through phosphorylation or stabilization of its phosphorylated form.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate FBXO41, leading to its activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can activate calcium-dependent kinases that phosphorylate FBXO41, hence increasing its activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin induces a rise in cytosolic calcium by inhibiting SERCA, which activates kinases that can phosphorylate FBXO41, leading to its activation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits protein phosphatases PP1 and PP2A, leading to a maintained phosphorylation state of FBXO41, corresponding with its activation. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A, similar to Okadaic Acid, inhibits PP1 and PP2A, maintaining FBXO41 in a phosphorylated and active state. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates the JNK pathway, which leads to the phosphorylation and subsequent activation of FBXO41. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 inhibits the proteasome, leading to accumulation of phosphorylated FBXO41 by preventing its degradation, which increases the active protein levels. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
Epoxomicin, a proteasome inhibitor, similarly leads to the accumulation of the active phosphorylated form of FBXO41. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, which reduces Akt activity. This reduction can lead to altered protein-protein interactions and phosphorylation states that activate FBXO41. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which through complex feedback mechanisms can lead to the dephosphorylation and activation of FBXO41. | ||||||